ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,80
0,76%
Dow Jones
38 789,07
0,03%
DAX
18 131,97
0,32%
Brent Oil
84,325
0,51%
Bitcoin
64 624,41
-2,80%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Idm Pharma (MM) (IDMI)

  7. Idm Pharma (MM) (IDMI) Actualités

IDMI

Idm Pharma (IDMI)

Idm Pharma (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IDMI
DateHeureSourceTitreSymboleSociété
24/06/200922h42Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:IDMIIdm Pharma (MM)
24/06/200922h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDMIIdm Pharma (MM)
24/06/200922h38Edgar (US Regulatory)(25-NSE)NASDAQ:IDMIIdm Pharma (MM)
23/06/200918h42Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:IDMIIdm Pharma (MM)
23/06/200915h40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:IDMIIdm Pharma (MM)
02/06/200905h14Dow Jones NewsCORRECT: Takeda's Millennium Looking For Deals To Bolster PipelineNASDAQ:IDMIIDM Pharma Inc.
01/06/200921h59Dow Jones NewsTakeda's Millennium Looking For Deals To Bolster PipelineNASDAQ:IDMIIDM Pharma Inc.
28/05/200920h07Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:IDMIIdm Pharma (MM)
26/05/200918h29Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:IDMIIdm Pharma (MM)
26/05/200918h17Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:IDMIIdm Pharma (MM)
19/05/200915h20PR Newswire (US)Stock Alerts on Tuesday's Small and Large-Cap Movers; Issued by Beacon EquityNASDAQ:IDMIIdm Pharma (MM)
18/05/200923h16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:IDMIIdm Pharma (MM)
18/05/200918h28Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:IDMIIdm Pharma (MM)
18/05/200918h05Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:IDMIIdm Pharma (MM)
18/05/200910h00PR Newswire (US)Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 YearNASDAQ:IDMIIdm Pharma (MM)
13/05/200922h42Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:IDMIIdm Pharma (MM)
11/05/200918h18Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IDMIIdm Pharma (MM)
11/05/200913h30PR Newswire (US)IDM Pharma Reports First Quarter Financial ResultsNASDAQ:IDMI
30/04/200919h57Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:IDMIIdm Pharma (MM)
13/04/200913h30PR Newswire (US)IDM Pharma Receives Nasdaq Shareholder Equity NotificationNASDAQ:IDMIIdm Pharma (MM)
03/04/200913h30PR Newswire (US)IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 FiscaNASDAQ:IDMIIdm Pharma (MM)
31/03/200922h30Edgar (US Regulatory)Annual Report (10-K)NASDAQ:IDMIIdm Pharma (MM)
31/03/200913h30PR Newswire (US)IDM Pharma Reports 2008 Financial ResultsNASDAQ:IDMIIdm Pharma (MM)
09/03/200916h26PR Newswire (US)IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, ResectNASDAQ:IDMIIdm Pharma (MM)
26/02/200914h00PR Newswire (US)IDM Pharma Joins NORD to Raise Awareness of Rare DiseasesNASDAQ:IDMIIdm Pharma (MM)
06/02/200920h15Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:IDMIIdm Pharma (MM)
04/02/200918h54Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IDMIIdm Pharma (MM)
18/12/200819h32PR Newswire (US)IDM Pharma Provides Update on Mifamurtide (MEPACT(R), L-MTP-PE) European Regulatory StatusNASDAQ:IDMIIdm Pharma (MM)
18/11/200813h30PR Newswire (US)IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-MetaNASDAQ:IDMIIdm Pharma (MM)
13/11/200813h30PR Newswire (US)IDM Pharma Reports Third Quarter Financial ResultsNASDAQ:IDMIIdm Pharma (MM)
 Showing the most relevant articles for your search:NASDAQ:IDMI

Dernières Valeurs Consultées

EU
ML
Michelin
NASDAQ
GOOGL
Alphabet
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
DG
Vinci
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
EU
LR
Legrand
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
EU
CAP
Capgemini
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés